Page last updated: 2024-08-24

3-iodobenzylguanidine and Sarcoidosis

3-iodobenzylguanidine has been researched along with Sarcoidosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AlJaroudi, WA; Hage, FG1
Beller, GA; Janardhanan, R1
Furui, S; Imai, E; Kaminaga, T; Kutomi, K; Takada, K1
Drent, M; Faber, CG; Gorgels, AP; Halders, SG; Heidendal, GA; Hoitsma, E; Kessels, AG; Reulen, JP; van Kroonenburgh, MJ1
Asoshina, M; Hokamura, Y; Honda, Y; Kimura, Y; Misumi, I; Nakashima, K; Shima, K; Takemura, N; Takenaka, S; Uranaka, N; Yasunaga, T1
Kinoshita, M; Matsui, T; Matsumoto, T; Matsuo, S; Nakamura, Y1

Reviews

2 review(s) available for 3-iodobenzylguanidine and Sarcoidosis

ArticleYear
Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 1 of 2: Positron emission tomography, computed tomography, and neuronal imaging.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2015, Volume: 22, Issue:3

    Topics: 3-Iodobenzylguanidine; Animals; Atherosclerosis; Cardiac Imaging Techniques; Cardiology; Clinical Trials as Topic; Humans; Mice; Multimodal Imaging; Neurons; Nuclear Medicine; Periodicals as Topic; Positron-Emission Tomography; Purines; Pyrazoles; Sarcoidosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2015
Radionuclide imaging in stage B heart failure.
    Heart failure clinics, 2012, Volume: 8, Issue:2

    Topics: 3-Iodobenzylguanidine; Asymptomatic Diseases; Cardiomyopathies; Chronic Disease; Coronary Artery Disease; Glucose; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Prognosis; Radionuclide Ventriculography; Radiopharmaceuticals; Sarcoidosis; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left

2012

Trials

1 trial(s) available for 3-iodobenzylguanidine and Sarcoidosis

ArticleYear
Scintigraphic detection of regional disruption of the adrenergic nervous system in sarcoid heart disease.
    Japanese circulation journal, 1996, Volume: 60, Issue:10

    Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Aged; Aged, 80 and over; Cardiomyopathies; Electrocardiography, Ambulatory; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Sarcoidosis; Thallium Radioisotopes

1996

Other Studies

3 other study(ies) available for 3-iodobenzylguanidine and Sarcoidosis

ArticleYear
Radioactive defect on I-123 MIBG myocardial SPECT imaging in a patient with cardiac sarcoidosis.
    Clinical nuclear medicine, 2002, Volume: 27, Issue:10

    Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Female; Humans; Radiopharmaceuticals; Sarcoidosis; Thallium; Tomography, Emission-Computed, Single-Photon

2002
Association of small fiber neuropathy with cardiac sympathetic dysfunction in sarcoidosis.
    Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2005, Volume: 22, Issue:1

    Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Case-Control Studies; Echocardiography, Doppler; Electrocardiography; Female; Heart; Heart Diseases; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon

2005
Detection of denervated but viable myocardium in cardiac sarcoidosis with I-123 MIBG and Tl-201 SPECT imaging.
    Annals of nuclear medicine, 2001, Volume: 15, Issue:4

    Topics: 3-Iodobenzylguanidine; Cardiomyopathies; Denervation; Heart Conduction System; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Sarcoidosis; Sympathetic Nervous System; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon

2001